[1]
Al-Humaidhi, A. 2020. A review study of targeting of AAK1 and JAK1/2 using baricitinib in COVID-19 infected human cells. AL-Kindy College Medical Journal. 16, supplement (Jul. 2020), 9-15. DOI:https://doi.org/10.47723/kcmj.v16isupplement.176.